scPharmaceuticals Inc. to Present at the 9th Annual SVB Leerink Global Healthcare Conference

BURLINGTON, Mass.--()--scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:00 a.m. ET on Tuesday, February 25, 2020, at the Lotte New York Palace Hotel in New York, NY.

Investors interested in arranging a meeting with the Company’s management during this conference should contact the conference coordinator.

About scPharmaceuticals

scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Contacts

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Christopher F. Brinzey
Westwicke, an ICR Company, 339-970-2843
chris.brinzey@westwicke.com

$Cashtags

Contacts

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Christopher F. Brinzey
Westwicke, an ICR Company, 339-970-2843
chris.brinzey@westwicke.com